Loading...
XKRX
001360
Market cap80mUSD
Jul 10, Last price  
1,305.00KRW
1D
1.87%
1Q
-27.78%
Jan 2017
-65.91%
Name

Samsung Pharm Co Ltd

Chart & Performance

D1W1MN
XKRX:001360 chart
P/E
10.64
P/S
2.67
EPS
122.66
Div Yield, %
—
Shrs. gr., 5y
6.82%
Rev. gr., 5y
-0.93%
Revenues
46.07b
+4.02%
32,802,727,00033,236,504,00037,057,787,00039,243,911,00044,078,652,92047,285,858,94046,920,574,89030,287,781,51042,164,637,26048,223,429,86041,919,468,82046,483,649,02044,566,363,00048,269,172,00054,901,130,00051,832,234,00051,955,038,00044,294,231,00046,074,380,000
Net income
11.55b
P
-2,356,850,000634,209,0001,316,511,000-906,230,000-1,748,024,980-3,132,252,050-18,488,789,520-23,748,181,000-994,386,000-21,617,603,000-7,539,887,910-2,075,705,8306,885,174,000-39,876,979,000-40,276,344,000-25,093,031,000-24,812,022,000-14,092,018,00011,545,102,000
CFO
-10.05b
L-41.89%
-1,492,388,0001,080,371,000-3,653,848,000-4,269,383,000-1,647,520,000-11,126,576,090603,654,480-13,583,335,010-4,204,949,290-9,941,381,0805,539,090,000-6,520,527,840-2,434,317,000-2,553,235,000-7,162,788,000-1,914,280,000-27,657,308,000-17,295,021,000-10,050,872,000

Notes

No notes on this company yet
Write a private note on this company, for your eyes only

Profile

SAMSUNG PHARM. Co., LTD. is a South Korean pharmaceutical company engaged in the manufacturing and distribution of a wide array of medical products. Its extensive portfolio includes a variety of prescription medications, encompassing treatments for conditions such as cancer (immunotherapy), pain, fever, and inflammation, obesity, high blood pressure, and arterial hardening, along with remedies for digestive disorders, phlegm, enzyme deficiencies, and osteoporosis. The company also supplies transfusion agents, skeletal muscle relaxants, antispasmodics, mixed vitamins, and antibiotics. Beyond these, SAMSUNG PHARM. provides general health and wellness products, including digestive aids, liver and circulatory system medications, cold remedies, nutritional supplements, health tonics, vitamins, energy drinks, and functional foods. Founded in 1929, the firm maintains its headquarters in Hwaseong-si, South Korea.
URL
https://www.sspharm.co.kr/new/main/main.php
IPO date
Jul 04, 1975
Employees
Domiciled in
KR
Incorporated in
KR

Valuation

Title
KRW in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122022‑122021‑122020‑122019‑122018‑122017‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT